Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

Discover last week's top S&P 500 healthcare gainers, major market stories, and groundbreaking pharma deals, including weight-loss drug updates.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Former Michigan quarterback J.J. McCarthy has been a name frequently mentioned since the Minnesota Vikings’ Wild Card loss to the Los Angeles Rams. McCarthy wasn’t on the field for the 27-9 ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

This collaboration unites Novo Nordisk’s deep therapeutic knowledge and drug development experience with Gensaic’s novel protein design technology with the aim to discover tissue targeting ...

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK1,000.00. The company’s shares closed yesterday at DKK657.07.

Rising second-year quarterback J.J. McCarthy has yet to play a regular season snap after missing his entire rookie campaign due to a knee injury. Sam Darnold stepped in and had the best season of ...

INDIANAPOLIS — As rookie quarterback J.J. McCarthy recovered from his torn meniscus last season, the Vikings felt it was important for him to get a firsthand look at his future. So as soon as he ...

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

Vikings head coach Kevin O'Connell gave encouraging injury updates on both Christian Darrisaw and J.J. McCarthy during his NFL combine press conference in Indianapolis on Tuesday. It's been four ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood ...